PATENT CLAIM ANALYSIS

Application Number: 16133072
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "534000"]

Abstract:
The present invention provides safe and effective methods for the treatment of sialorrhea (excessive drooling) by administering an effective amount of N desethyloxybutynin, or an optical R- or S-isomer thereof or a pharmaceutically acceptable salt thereof.

Claim (Index 3):
The method of  claim 1 , wherein the N-desethyloxybutynin is administered via oral, buccal, transdermal, inhalation, implantation, vaginal or rectal route of administration.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.17647
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10731039', '11246558', '10913019', '10286381', '10731040']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7605193887722539
- 35 USC 102 Novelty (BERT): 0.4815848245796253
- Combined Prediction Score: 0.732625932352991
- Mean Citation Score: 178.88611999999995
- Max Citation Score: 183.1171
- Similarity Product: 134.5926973993361

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test